Reininger Cornelia 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 19, 2013
Insider Transaction Report
Form 4
Reininger Cornelia
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-02-15+120,000→ 120,000 totalExercise: $3.08Exp: 2023-02-15→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.